Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 16;22(1):27.
doi: 10.1186/s12863-021-00982-3.

Complete genome sequence of an extensively drug resistant (XDR) M. morganii SMM01 isolated from a patient with urinary and fecal incontinence

Affiliations

Complete genome sequence of an extensively drug resistant (XDR) M. morganii SMM01 isolated from a patient with urinary and fecal incontinence

Pachi Pulusu Chanakya et al. BMC Genom Data. .

Abstract

Objective: M. morganii is a gram-negative, non-lactose fermenting and an opportunistic pathogen frequently associated with nosocomial infections. Although first isolated in 1906 from a pediatric fecal sample, not many M. morganii isolates have been sequenced. The objective of this work is to determine the complete genome sequence of an XDR M. morganii strain (SMM01) isolated from the urine of a patient with urinary and fecal incontinence and to characterize its antimicrobial resistance profile.

Data description: Here, we report the complete genome sequence of M. morganii SMM01 generated from the hybrid assembly of Illumina HiSeq X and Nanopore MinION reads. The assembly is 100% complete with genome size of 39,30,130 bp and GC content of 51%. Genomic features include 3617 CDS, 18 rRNAs, 78 tRNAs, 4 ncRNAs and 60 pseudogenes. Antimicrobial resistance profile was characterized by the presence of genes conferring resistance to aminoglycosides, β-lactams, fluoroquinolones, chloramphenicol, and tetracyclines. Secondary metabolite biosynthetic gene clusters like NRPS, T1PKS, thiopeptide, beta-lactone, and bacteriocin were identified. The genome data described here would be the first complete genome of an Indian M. morganii isolate providing crucial information on antimicrobial resistance patterns, paving the way for further comparative genome analyses.

Keywords: Complete genome and antimicrobial resistance (AMR); Extensively drug resistant (XDR); Hybrid sequencing; M. morganii.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Morgan HDR, Oxon MA. Report CII. Upon the bacteriology of the summer Diarrhoea of infants. Br Med J. 1907;2(2427):16–19. doi: 10.1136/bmj.2.2427.16-a. - DOI - PMC - PubMed
    1. O'Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev. 2000;13(4):534–546. doi: 10.1128/CMR.13.4.534. - DOI - PMC - PubMed
    1. Lin TY, Chan MC, Yang YS, Lee Y, Yeh KM, Lin JC, Chang FY. Clinical manifestations and prognostic factors of Morganella morganii bacteremia. Eur J Clin Microbiol Infect Dis. 2015;34(2):231–236. doi: 10.1007/s10096-014-2222-8. - DOI - PubMed
    1. Liu H, Zhu J, Hu Q, Rao X. Morganella morganii, a non-negligent opportunistic pathogen. Int J Infect Dis. 2016;50:10–17. doi: 10.1016/j.ijid.2016.07.006. - DOI - PubMed
    1. CLSI . Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100. 30. Wayne: Clinical and Laboratory Standards Institute; 2020.

Publication types

Substances